WCPO: Local doctor helps design app to help Black community fight COVID-19
UC cardiologist collaborates with researchers in St. Louis and Georgia
Donald Lynch, MD, assistant professor in the UC Division of Cardiovascular Health and Disease, is developing a smartphone app designed to provide better information and education that will reach African-American communities which are disproportionately affected by the COVID-19 pandemic.
Lynch, also a UC Health cardiologist, spoke with WCPO for a segment as the number of COVID-19 cases continues to increase. As of Nov. 15, there were 298,096 cases of COVID-19 in Ohio, according to the Ohio Department of Health. Black residents make up 14 percent of Ohio’s population but accounted for 23 percent or 5,205 of the 22,265 hospitalizations stemming from COVID-19.
Listen to Lynch interview with WCPO.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.